bictegravir/emtricitabine/tenofovir alafenamide(Biktarvy)
Antiretroviral (INSTI + 2 NRTI single-tablet regimen)
Pronunciation
/bɪkˈtɛɡrəvɪr/
International Phonetic Alphabet (IPA). Say it aloud once — you will remember it forever.
At a glance
- Generic name
- bictegravir/emtricitabine/tenofovir alafenamide
- Brand names
- Biktarvy
- Therapeutic class
- Antiretroviral (INSTI + 2 NRTI single-tablet regimen)
- Mechanism (summary)
- <!-- AI-DRAFTED: 2026-06-24 -->
Clinical pearls
- Take once daily, same time each day.
- Separate from antacids, iron, calcium, multivitamins by 2h before or 6h after.
- Do not stop without consulting provider - resistance can develop.
- Report yellowing of skin/eyes, dark urine, severe muscle pain.
- Continue contraception/safe sex - does not prevent HIV transmission risk to others if not virally suppressed.
Sources
See how bictegravir/emtricitabine/tenofovir alafenamide appears in NAPLEX-style questions
PharmDHub Premium includes a full drug card, dosing, boxed warnings, drug-drug interactions, and practice questions built around this drug.